StockData

Criteo vs Teads

CRTO and TEAD side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CRTO and TEAD compare

Criteo is the larger company, worth 64 times as much as Teads ($908M against $14.2M).

Teads grew revenue faster over the last twelve months (12.3% versus 0.60% for Criteo).

Criteo keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with −43.3% at Teads.

Criteo scores higher on the StockData Score (19 against 3 for Teads), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCRTOTEAD
Size and price
Market cap$908M$14.2M
Share price$18.54$0.145
Change, 1 year−10.7%−81.5%
Change, 5 years−52.8%−99.0%
Beta (5Y)0.692.88
Employees1,1811,700
StockData Score
Total score19 (better)3
Valuation score6 (better)1
Growth score3 (better)2
Performance score5 (better)0
Health score5 (better)0
Dividend score00
Valuation
P/E7.0×–
P/S0.5×0.0× (better)
P/B0.8× (better)1.9×
EV/EBITDA3.3×–
P/FCF4.4×–
PEG0.04–
FCF yield23.0% (better)−320%
Fair value$49.81–
Margin of safety62.8%–
Growth
Revenue growth (TTM)0.60%12.3% (better)
Revenue growth, 5Y average−1.3%11.1% (better)
Net income growth (TTM)29.6%–
EPS growth (TTM)38.9%–
EPS growth, 5Y average17.9%–
Profitability
Gross margin54.0% (better)33.2%
Operating margin10.4% (better)−31.9%
Net margin7.4% (better)−43.3%
FCF margin10.7% (better)−3.7%
Return on equity13.0% (better)−196%
Return on invested capital17.4% (better)−201%
Financial health
Debt / equity0.000.96 (better)
Interest coverage82.4× (better)−5.6×
Current ratio1.29 (better)0.98
Altman Z-score2.48 (better)−0.98
Piotroski F-score9 (better)5
Dividends and buybacks
Buyback yield16.7% (better)1.4%
Shareholder yield16.7% (better)1.4%
Ownership
Held by institutions83.9%20.6%
Held by insiders4.0%63.6%
Insider net buying, 12 months−$1.5M$164K (better)
Short interest, % of float2.6%9.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.